VSee Health, Inc. Proceeds from Notes Payable
VSee Health, Inc. (VSEE) reported Proceeds from Notes Payable of $240.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-04-12.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromNotesPayable · last filed 2024-09-23
- VSee Health, Inc. proceeds from notes payable for the quarter ending 2023-12-31 was -$10.00K.
- VSee Health, Inc. proceeds from notes payable for the quarter ending 2023-09-30 was $50.00K.
- VSee Health, Inc. proceeds from notes payable for the quarter ending 2023-06-30 was -$50.00K.
- VSee Health, Inc. proceeds from notes payable for the quarter ending 2023-03-31 was $250.00K.
- VSee Health, Inc. proceeds from notes payable for fiscal 2023 was $240.00K.
| Period end | Proceeds from Notes Payable 3 month | Proceeds from Notes Payable 6 month | Proceeds from Notes Payable 6 month as first filed | Proceeds from Notes Payable 9 month | Proceeds from Notes Payable 12 month |
|---|---|---|---|---|---|
| 2023-12-31 | -$10.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-12 | $40.00K derived: sum of 2 quarters · filed 2024-04-12 | -$10.00K derived: sum of 3 quarters · filed 2024-09-23 | $240.00K 10-K · filed 2024-04-12 | |
| 2023-09-30 | $50.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-20 | $0.00 derived: sum of 2 quarters · filed 2024-09-23 | $250.00K 10-Q · filed 2023-11-20 | ||
| 2023-06-30 | -$50.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-09-23 | $200.00K 10-Q · filed 2024-09-23 | $240.00K 10-Q · filed 2023-08-21 | ||
| 2023-03-31 | $250.00K 10-Q · filed 2024-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Agape ATP Corp (ATPC) | $0.002B | ||
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |